BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chogtu B, Magazine R, Bairy K. Statin use and risk of diabetes mellitus. World J Diabetes 2015; 6(2): 352-357 [PMID: 25789118 DOI: 10.4239/wjd.v6.i2.352]
URL: https://www.wjgnet.com/1948-9358/full/v6/i2/352.htm
Number Citing Articles
1
Fathi M Sherif. A Comparative Study of Metformin alone, in Combination with Insulin or Metformin Plus Insulin in Presence of Simvastatin in Libyan Diabetic PatientsPharmacy & Pharmacology International Journal 2017; 5(2) doi: 10.15406/ppij.2017.05.00116
2
Niki Katsiki, Francesco Purrello, Costas Tsioufis, Dimitri P. Mikhailidis. Cardiovascular disease prevention strategies for type 2 diabetes mellitusExpert Opinion on Pharmacotherapy 2017; 18(12): 1243 doi: 10.1080/14656566.2017.1351946
3
Konstantinos Stavropoulos, Konstantinos Imprialos, Michael Doumas, Vasilios G. Athyros. What is the role of statins in the elderly population?Expert Review of Clinical Pharmacology 2018; 11(4): 329 doi: 10.1080/17512433.2018.1439737
4
B.L. Furman. Reference Module in Biomedical Sciences2017;  doi: 10.1016/B978-0-12-801238-3.98060-7
5
Kashyap Pandya, Cesar A. Lau-Cam. Taurine 11Advances in Experimental Medicine and Biology 2019; 1155: 87 doi: 10.1007/978-981-13-8023-5_8
6
Gizem Uzunoğlu, Duygu Çimen, Nilay Bereli, Kemal Çetin, Adil Denizli. Cholesterol removal from human plasma with biologically modified cryogelsJournal of Biomaterials Science, Polymer Edition 2019; 30(14): 1276 doi: 10.1080/09205063.2019.1627652
7
Nisha Khatiwada, Zhongkui Hong. Potential Benefits and Risks Associated with the Use of StatinsPharmaceutics 2024; 16(2): 214 doi: 10.3390/pharmaceutics16020214
8
Jonathan T. Davies, Spencer F. Delfino, Chad E. Feinberg, Meghan F. Johnson, Veronica L. Nappi, Joshua T. Olinger, Anthony P. Schwab, Hollie I. Swanson. Current and Emerging Uses of Statins in Clinical Therapeutics: A ReviewLipid Insights 2016; 9 doi: 10.4137/LPI.S37450
9
Farzad Masoudkabir, Nizal Sarrafzadegan, Carolyn Gotay, Andrew Ignaszewski, Andrew D. Krahn, Margot K. Davis, Christopher Franco, Arya Mani. Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic preventionAtherosclerosis 2017; 263: 343 doi: 10.1016/j.atherosclerosis.2017.06.001
10
Aris P Agouridis, Michael S Kostapanos, Moses S Elisaf. Statins and their increased risk of inducing diabetesExpert Opinion on Drug Safety 2015; 14(12): 1835 doi: 10.1517/14740338.2015.1096343
11
Greisa Vila, Alois W. Gessl, Michaela Riedl, Anton Luger. Andere spezifische DiabetesformenWiener klinische Wochenschrift 2016; 128(S2): 208 doi: 10.1007/s00508-016-0997-6
12
Charles D. Ponte, Devra K. Dang. Textbook of Diabetes2017; : 262 doi: 10.1002/9781118924853.ch19
13
Ji Bak Kim, Woo Hyuk Song, Jong Sung Park, Tae-Jin Youn, Yong Hyun Park, Shin-Jae Kim, Sung Gyun Ahn, Joon-Hyung Doh, Yun-Hyeong Cho, Jin Won Kim, Giuseppe Danilo Norata. A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemiaPLOS ONE 2021; 16(1): e0245481 doi: 10.1371/journal.pone.0245481
14
Laongdao Thongnak, Anchalee Pongchaidecha, Krit Jaikumkao, Varanuj Chatsudthipong, Nipon Chattipakorn, Anusorn Lungkaphin. The additive effects of atorvastatin and insulin on renal function and renal organic anion transporter 3 function in diabetic ratsScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-13206-5
15
Johanna Andrea Gutiérrez-Vargas, Gloria Patricia Cardona-Gómez. Considering risk factors for the effectiveness of translational therapies in brain strokeJournal of the Neurological Sciences 2020; 408: 116547 doi: 10.1016/j.jns.2019.116547
16
慧 王. Statins and the Risk, Mechanism and Research Progress of New Onset Diabetes MellitusAdvances in Clinical Medicine 2023; 13(12): 20578 doi: 10.12677/ACM.2023.13122894
17
Kinga-Ilona Nyulas, Zsuzsánna Simon-Szabó, Zoltán Preg, Sándor Pál, Arundhati Sharma, Tünde Pál, Márta Germán-Salló, Enikő Nemes-Nagy. Assessment of Vitamin D Levels in Relation to Statin Therapy in Elderly Hypertensive Patients with ComorbiditiesJournal of Interdisciplinary Medicine 2022; 7(4): 88 doi: 10.2478/jim-2022-0021
18
Fadia Mayyas, Tala Al Gharram. Impact of atorvastatin on plasma and cardiac biomarkers of inflammation, oxidative stress, and fibrosis in a rat model of streptozotocin-induced diabetesNaunyn-Schmiedeberg's Archives of Pharmacology 2023; 396(2): 261 doi: 10.1007/s00210-022-02318-z
19
Kyeong-Ju Lee, Yoon-Mi Lee, Seong-Bin Yang, Jun-Hyuck Lee, Ha Rin Kim, Ji-Hong Lim, Jooho Park. A novel chemically engineered multifunctional statin conjugate as self-assembled nanoparticles inhibiting bile acid transportersJournal of Controlled Release 2024; 372: 885 doi: 10.1016/j.jconrel.2024.07.008
20
Hirotaka Watada, Yasushi Kawakita, Keiko Tanaka, Akinori Oh, Nobuhiro Nishigaki, Tadashi Nakajima, Keita Fujikawa, Manabu Akazawa. A Claims-Based Cohort Study on the Treatment Patterns of Japanese Patients with Type 2 Diabetes Mellitus and the Association of Early First Physician Visit with Time to Prescription of Oral Hypoglycemic AgentsDiabetes Therapy 2021; 12(7): 2035 doi: 10.1007/s13300-021-01090-2
21
Rui Xue, Dingkun Gui, Liyang Zheng, Ruonan Zhai, Feng Wang, Niansong Wang. Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future PerspectiveJournal of Diabetes Research 2017; 2017: 1 doi: 10.1155/2017/1839809
22
Sharon Rees. A practical guide to prescribing statins in primary carePractice Nursing 2018; 29(8): 377 doi: 10.12968/pnur.2018.29.8.377
23
Markku Laakso, Lilian Fernandes Silva. Statins and risk of type 2 diabetes: mechanism and clinical implicationsFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1239335
24
V.A. Serhiyenko, A.A. Serhiyenko. Цукровий діабет, дисліпопротеїнемії та статиниEndokrynologia 2022; 27(1): 29 doi: 10.31793/1680-1466.2022.27-1.29
25
Thaer Idrees, Wesley H Prieto, Sabina Casula, Aswathy Ajith, Matthew Ettleson, Flavia A Andreotti Narchi, Pedro S T Russo, Fernando Fernandes, Julie Johnson, Anoop Mayampurath, Rui M B Maciel, Antonio C Bianco. Use of Statins Among Patients Taking Levothyroxine: an Observational Drug Utilization Study Across SitesJournal of the Endocrine Society 2021; 5(7) doi: 10.1210/jendso/bvab038
26
Yu Hyun Kwon, Seul-Ki Kim, Jung Hwan Cho, Hyemi Kwon, Se Eun Park, Hyung-Geun Oh, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee. The Association between Persistent Hypertriglyceridemia and the Risk of Diabetes Development: The Kangbuk Samsung Health StudyEndocrinology and Metabolism 2018; 33(1): 55 doi: 10.3803/EnM.2018.33.1.55
27
Marc-André Legault, Jean-Claude Tardif, Marie-Pierre Dubé. Pharmacogenomics of Blood Lipid RegulationPharmacogenomics 2018; 19(7): 651 doi: 10.2217/pgs-2018-0007
28
Alicia J. Jenkins, Emma Scott, Jordan Fulcher, Gary Kilov, Andrzej S. Januszewski. Comprehensive Cardiovascular Medicine in the Primary Care SettingContemporary Cardiology 2019; : 113 doi: 10.1007/978-3-319-97622-8_7
29
V. D. Sargsyan, T. V. Kamyshova, A. S. Safaryan, N. M. Akhmedzhanov, D. V. Nebieridze, E. A. Poddubskaya. Statins in real clinical practice: current guidelines, possibilities of new schemes for their useProfilakticheskaya meditsina 2019; 22(3): 86 doi: 10.17116/profmed20192203186
30
Charles D. Ponte, Devra K. Dang. Textbook of Diabetes2024; : 295 doi: 10.1002/9781119697473.ch21
31
Dipender Gill, Marie-Joe Dib, Rubinder Gill, Stefan R. Bornstein, Stephen Burgess, Andreas L. Birkenfeld. Effects of ACLY Inhibition on Body Weight Distribution: A Drug Target Mendelian Randomization StudyGenes 2024; 15(8): 1059 doi: 10.3390/genes15081059
32
Kyung-Yeon Park, Euichaul Oh, Mi-Kyoung Kwak, Hyun Sik Jun, Tae-Hwe Heo, Yeonseok Chung. Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout MicePLOS ONE 2016; 11(3): e0150791 doi: 10.1371/journal.pone.0150791
33
Haruna Hatahira, Toshinobu Matsui, Yamato Kato, Natsumi Ueda, Junko Abe, Sayaka Sasaoka, Yumi Motooka, Yuuki Hane, Yasutomi Kinosada, Chitoshi Goto, Mitsuhiro Nakamura. Risk Analysis of New-onset Impaired Glucose Tolerance with Statins by Using a Spontaneous Reporting Database of Adverse EventsIryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 2016; 42(2): 98 doi: 10.5649/jjphcs.42.98
34
Retno Indrati. Legumes Research - Volume 22022;  doi: 10.5772/intechopen.99979
35
Souty M. Z. Sharkawi, Ehab A. M. El-Shoura, Amira M. Abo-Youssef, Ramadan A. M. Hemeida. The potential hepatoprotective effects of lovastatin combined with oral hypoglycemic agents in streptozotocin-induced diabetes in ratsImmunopharmacology and Immunotoxicology 2020; 42(2): 165 doi: 10.1080/08923973.2020.1733013
36
Jyotsna Needamangalam Balaji, Sreenidhi Prakash, Ashish Joshi, Krishna Mohan Surapaneni. A Scoping Review on the Reported Evidence and Gaps of the Risk of Diabetes in Dyslipidemic Patients under Statin TherapyClinics and Practice 2022; 12(4): 565 doi: 10.3390/clinpract12040060
37
Bin Deng, Shijun Li, Ruxu You, Zhiwen Fu. Diabetic adverse events associated with three commonly used statins: a disproportionality analysis based on the FDA adverse event reporting system databaseExpert Opinion on Drug Safety 2024; : 1 doi: 10.1080/14740338.2024.2418325
38
Kei Nakajima, Ryoko Higuchi, Taizo Iwane, Michi Shibata, Kento Takada, Michiko Sugiyama, Masafumi Matsuda, Teiji Nakamura. High Incidence of Diabetes in People with Extremely High High-Density Lipoprotein Cholesterol: Results of the Kanagawa Investigation of Total Checkup Data from the National Database-1 (KITCHEN-1)Journal of Clinical Medicine 2019; 8(3): 381 doi: 10.3390/jcm8030381
39
Sherin Hijazi, Nadim Obeid, Riad Jabri. On Drug Dosage Control Using Description Defeasible Logic2017 International Conference on Computational Science and Computational Intelligence (CSCI) 2017; : 1654 doi: 10.1109/CSCI.2017.288
40
Jinkwon Kim, Hye Sun Lee, Kyung-Yul Lee. Effect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in KoreaCardiovascular Diabetology 2018; 17(1) doi: 10.1186/s12933-018-0799-4
41
Joana Camões Neves, João Sérgio Neves, Celestino Neves, Davide Carvalho. Predictors of the effectiveness of insulin pumps in patients with type 1 diabetes mellitusEndocrine 2022; 75(1): 119 doi: 10.1007/s12020-021-02837-4
42
Dipanjan Bhattacharjee, Bharti Chogtu, Rahul Magazine. Statins in Asthma: Potential Beneficial Effects and LimitationsPulmonary Medicine 2015; 2015: 1 doi: 10.1155/2015/835204
43
Fares Alahdab, Feras Zaiem, Zhen Wang, M Hassan Murad. Interpreting meta-analysis of continuous outcomes with pre and postvaluesEvidence Based Medicine 2016; 21(4): 139 doi: 10.1136/ebmed-2016-110493
44
Eduardo Filipe Oliveira, Diogo Santos-Martins, António Meireles Ribeiro, Natércia Fernandes Brás, Nuno Sousa Cerqueira, Sérgio Filipe Sousa, Maria João Ramos, Pedro Alexandrino Fernandes. HMG-CoA Reductase inhibitors: an updated review of patents of novel compounds and formulations (2011-2015)Expert Opinion on Therapeutic Patents 2016; 26(11): 1257 doi: 10.1080/13543776.2016.1216977
45
Sarah Cuschieri, Josanne Vassallo, Neville Calleja, Christopher Barbara, Julian Mamo. The interaction of dyslipidaemia with glycaemia in an adult population studyJournal of Diabetes & Metabolic Disorders 2018; 17(2): 315 doi: 10.1007/s40200-018-0377-z
46
Girish A. Ghadge, Karthik Gourishetti, Mallikarjuna Rao Chamallamudi, Gopalan Kutty Nampurath, Krishnadas Nandakumar, Nitesh Kumar. Sesamol protects MIN6 pancreatic beta cells against simvastatin-induced toxicity by restoring mitochondrial membrane potentials3 Biotech 2020; 10(4) doi: 10.1007/s13205-020-2146-1
47
Yaxin Luo, Yaofeng Hou, Wenwen Zhao, Bei Yang. Recent progress in gene therapy for familial hypercholesterolemia treatmentiScience 2024; 27(9): 110641 doi: 10.1016/j.isci.2024.110641
48
Mohammad Shoaib Hamrah, Mohammad Hassan Hamrah, Mohammad Hussain Hamrah, Toba Dahi, Mohammad Hashem Hamrah. Screening and management of statin cause a case of prediabetes in an outpatient clinic in Afghanistan: a case report in Andkhoy CityThe Egyptian Journal of Internal Medicine 2019; 31(3): 382 doi: 10.4103/ejim.ejim_109_18
49
Angeliki M. Angelidi, Emelina Stambolliu, Konstantina I. Adamopoulou, Antonis A. Kousoulis. Is Atorvastatin Associated with New Onset Diabetes or Deterioration of Glycemic Control? Systematic Review Using Data from 1.9 Million PatientsInternational Journal of Endocrinology 2018; 2018: 1 doi: 10.1155/2018/8380192